Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients.

Gilbert SF, Soliman AS, Karkouri M, Quinlan-Davidson M, Strahley A, Eissa M, Dey S, Hablas A, Seifeldin IA, Ramadan M, Benjaafar N, Toy K, Merajver SD.

Breast Dis. 2011;33(1):17-26. doi: 10.3233/BD-2010-0323.

2.

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.

Ottini L, Rizzolo P, Zanna I, Falchetti M, Masala G, Ceccarelli K, Vezzosi V, Gulino A, Giannini G, Bianchi S, Sera F, Palli D.

Breast Cancer Res Treat. 2009 Aug;116(3):577-86. doi: 10.1007/s10549-008-0194-z. Epub 2008 Sep 26.

PMID:
18819001
3.

Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients.

Gilbert SF, Soliman AS, Iniesta M, Eissa M, Hablas A, Seifeldin IA, Strahley A, Banerjee M, Merajver SD.

Breast Cancer Res Treat. 2011 Sep;129(2):575-81. doi: 10.1007/s10549-011-1510-6. Epub 2011 Apr 20.

4.

Long CAG repeat sequence and protein expression of androgen receptor considered as prognostic indicators in male breast carcinoma.

Song YN, Geng JS, Liu T, Zhong ZB, Liu Y, Xia BS, Ji HF, Li XM, Zhang GQ, Ren YL, Li ZG, Pang D.

PLoS One. 2012;7(12):e52271. doi: 10.1371/journal.pone.0052271. Epub 2012 Dec 14.

5.

Increased frequency of long androgen receptor CAG repeats in male breast cancers.

MacLean HE, Brown RW, Beilin J, Warne GL, Zajac JD.

Breast Cancer Res Treat. 2004 Dec;88(3):239-46.

PMID:
15609126
6.

BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.

Kwiatkowska E, Teresiak M, Filas V, Karczewska A, Breborowicz D, Mackiewicz A.

Clin Cancer Res. 2003 Oct 1;9(12):4452-9.

7.

Length of androgen receptor-CAG repeats in fertile and infertile Egyptian men.

Badran WA, Fahmy I, Abdel-Megid WM, Elder K, Mansour R, Kent-First M.

J Androl. 2009 Jul-Aug;30(4):416-25. doi: 10.2164/jandrol.108.005843. Epub 2009 Jan 22.

8.

Androgen receptor gene alterations in Finnish male breast cancer.

Syrjäkoski K, Hyytinen ER, Kuukasjärvi T, Auvinen A, Kallioniemi OP, Kainu T, Koivisto PA.

Breast Cancer Res Treat. 2003 Jan;77(2):167-70.

PMID:
12602915
9.

Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.

Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD.

J Clin Oncol. 2002 Sep 1;20(17):3599-604.

PMID:
12202660
10.

Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy.

Miolo G, Puppa LD, Santarosa M, De Giacomi C, Veronesi A, Bidoli E, Tibiletti MG, Viel A, Dolcetti R.

BMC Cancer. 2006 Jun 9;6:156.

11.

Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco.

Soliman AS, Kleer CG, Mrad K, Karkouri M, Omar S, Khaled HM, Benider AL, Ayed FB, Eissa SS, Eissa MS, McSpadden EJ, Lo AC, Toy K, Kantor ED, Xiao Q, Hampton C, Merajver SD.

Breast Dis. 2011-2012;33(4):159-69. doi: 10.3233/BD-2012-000337.

12.

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.

Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M, Peterlongo P, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2012 Jul;134(1):411-8. doi: 10.1007/s10549-012-2062-0. Epub 2012 Apr 18.

PMID:
22527108
13.

Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):127-35.

14.

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Spurdle AB, Antoniou AC, Duffy DL, Pandeya N, Kelemen L, Chen X, Peock S, Cook MR, Smith PL, Purdie DM, Newman B, Dite GS, Apicella C, Southey MC, Giles GG, Hopper JL, Chenevix-Trench G, Easton DF; EMBRACE Study Collaborators.

Breast Cancer Res. 2005;7(2):R176-83. Epub 2004 Dec 16.

15.

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.

Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA.

Br J Cancer. 2001 Jul 6;85(1):36-40.

16.

Male breast cancer.

Joseph A, Mokbel K.

Int J Fertil Womens Med. 2004 Sep-Oct;49(5):198-9. Review.

PMID:
15633473
17.

CAG repeat length in androgen receptor gene and male infertility in Egyptian patients.

Mosaad YM, Shahin D, Elkholy AA, Mosbah A, Badawy W.

Andrologia. 2012 Feb;44(1):26-33. doi: 10.1111/j.1439-0272.2010.01100.x. Epub 2011 Apr 6.

PMID:
21486420
18.

Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.

De Abreu FB, Pirolo LJ, Canevari Rde A, Rosa FE, Moraes Neto FA, Caldeira JR, Rainho CA, Rogatto SR.

Anticancer Res. 2007 Mar-Apr;27(2):1199-205.

19.

Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer.

Yu H, Bharaj B, Vassilikos EJ, Giai M, Diamandis EP.

Breast Cancer Res Treat. 2000 Jan;59(2):153-61.

PMID:
10817350
20.

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.

Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M.

Am J Hum Genet. 1999 May;64(5):1371-7.

Supplemental Content

Support Center